The primary endpoint is to determine the number of days it takes to achieve a 50% reduction in blister count, and secondary endpoints include a reduction of baseline prednisone dose once the primary endpoint has been achieved. The trial will…
- Accueil
- Qui sommes-nous
- Vivant avec P/P
- Recherche
- Impliquez-vous
- Actualités & Info
- Forums de discussion
